Evidence map›Paper›PMID 34603769›Full record

ArticleImmunometabolism2021

Bad Cholesterol Uptake by CD36 in T-Cells Cripples Anti-Tumor Immune Response.

Mikhail G Kolonin

Open access · diamondAbstract readComment
In one paragraph

Article in Immunometabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mikhail G KoloninThe Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
Brown Foundation · US

Funding

The Roles of Lipid Metabolism in the Maintenance of Hematopoietic Stem CellsR01DK098263 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Keisuke Ito · 2013 to 2026
$5.2M
The Function of Prohibitin / Annexin 2 Interaction in White Adipose TissueR01DK088131 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOLONIN, MIKHAIL G · 2010 to 2021
$3.1M
NIDDK NIH HHS R01 DK088131NIDDK NIH HHS R01 DK098263
6 · The paper itself

Abstract

Despite the advances in immunotherapies, effective against some types of cancer, progression of several types of carcinoma remains uncurable. Recent studies indicate that changes in lipid metabolism, aggravated by obesity, disable anti-tumor immune response. In the July issue of

Indexed as

anti-tumor immune responsecholesterolT-cells

Identifiers

PMID34603769
PMCPMC8486286
OpenAlexW3201539773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.